Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. March 21, 2018. Jason Bhan.

Executive Summary

Start-up firm Prognos has a lofty long-term mission: to use artificial intelligence and other smart technologies to eradicate disease. Check out what company cofounder Jason Bhan had to say about Prognos' use of AI here.

"Our vision is to use the data and the product and the capabilities we have to eradicate disease. In the interim – over the next five years – we will figure out how to predict where disease is going to occur and enable others to intervene at those points, so we can help people get diagnosed and then treated faster." –Jason Bhan, cofounder and chief medical officer, Prognos

Find out more: Start-Up Spotlight: Payers, Pharma Clients Bank On Prognos' Artificial Intelligence To Predict Disease

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel